Sonnet BioTherapeutics Holdings, Inc.
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human sin…
Biotechnology
US, Princeton [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Sonnet BioTherapeutics Holdings, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDSonnet BioTherapeutics Holdings, Inc. can't present revenue by segment